COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 365: Articles 3641-3650  | Next

Comparative performance of COVID-19 test methods in healthcare workers during the omicron wave
Tornberg, E. C., Tomlinson, A., Oshiro, N. T. T., Derfalie, E., Curlin, M.
10.1101/2023.09.25.23296099 — Posted: 2023-09-26
Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort
Echeverri Tribin, F., Williams, E., Testamarck, V., Carreno, J. M., Bielak, D., Yellin, T., Krammer, F., Hoffer, M., Pallikkuth, S., Pahwa, S.
10.1101/2023.09.25.23296114 — Posted: 2023-09-26
Near-term forecasting of Covid-19 cases and hospitalisations in Aotearoa New Zealand
Plank, M. J., Watson, L. M., Maclaren, O. J.
10.1101/2023.09.25.23296118 — Posted: 2023-09-26
Evaluation of computer vision syndrome in the sample of students from the College of Medicine/University of Kerbala result of online learning with the isolation of COVID-19
AbuRagheif, m. h.
10.1101/2023.09.25.23295828 — Posted: 2023-09-26
Structural and functional insights into the enzymatic plasticity of the SARS-CoV-2 NiRAN Domain
Small, G. I., Federova, O., Olinares, P. D. B., Chandanani, J., Banerjee, A., Choi, Y. J., Molina, H., Chait, B., Darst, S. A., Campbell, E. A.
10.1101/2023.09.25.558837 — Posted: 2023-09-26
RCoV19: A One-stop Hub for SARS-CoV-2 Genome Data Integration, Variants Monitoring, and Risk Pre-warning
Li, C., Ma, L., Zou, D., Zhang, R., Bai, X., Li, L., Wu, G., Huang, T., Zhao, W., Jin, E., Bao, Y., Song, S.
10.1101/2023.09.24.558358 — Posted: 2023-09-26
Using a function-first "scout fragment"-based approach to develop allosteric covalent inhibitors of conformationally dynamic helicase mechanoenzymes
Ramsey, J. R., Shelton, P. M. M., Heiss, T. K., Olinares, P. D. B., Vostal, L. E., Soileau, H., Grasso, M., Warrington, S., Adaniya, S., Miller, M., Sun, S., Huggins, D. J., Myers, R. W., Chait, B. T., Vinogradova, E. V., Kapoor, T. M.
10.1101/2023.09.25.559391 — Posted: 2023-09-26
In silico analyses identify sequence contamination thresholds for Nanopore-generated SARS-CoV-2 sequences
Bolaji, A., Duggan, A. T.
10.1101/2023.09.26.559465 — Posted: 2023-09-26
Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10
Lopez-Ayllon, B. D., Marin, S., Farinas Fernandez, M., Garcia-Garcia, T., Fernandez-Rodriguez, R., de Lucas-Rius, A., Redondo, N., Mendoza-Garcia, L., Foguet, C., Grigas, J., Calvet, A., Villalba, J. M., Rodriguez Gomez, M. J., Megias, D., Mandracchia, B., Luque, D., Lozano, J. J., Calvo, C., Thomson, T. M., Garrido, J. J., Cascante, M., Montoya, M.
10.1101/2023.09.26.559506 — Posted: 2023-09-26
Omicron Breakthrough Infection Elicits Superior Humoral and Mucosal Immune Responses to SARS-CoV-2 Variants than an Intramuscular Booster Dose
Nantel, S., Sheikh-Mohamed, S., Chao, G. Y. C., Kurtesi, A., Hu, Q., Wood, H., Colwill, K., Li, Z., Liu, Y., Seifried, L., Bourdin, B., McGeer, A., Hardy, W. R., Rojas, O. L., Ostrowski, M. A., Brockman, M. A., Piccirillo, C. A., Quach, C., Rini, J. M., Gingras, A.-C., Decaluwe, H., Gommerman, J. L.
10.1101/2023.09.22.23295541 — Posted: 2023-09-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).